{
    "body": "Does administration of triiodothyronine improve outcome following coronary artery bypass grafting?", 
    "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/18290900", 
        "http://www.ncbi.nlm.nih.gov/pubmed/16820580", 
        "http://www.ncbi.nlm.nih.gov/pubmed/19303793", 
        "http://www.ncbi.nlm.nih.gov/pubmed/8633935", 
        "http://www.ncbi.nlm.nih.gov/pubmed/19609889", 
        "http://www.ncbi.nlm.nih.gov/pubmed/7995828", 
        "http://www.ncbi.nlm.nih.gov/pubmed/12213743", 
        "http://www.ncbi.nlm.nih.gov/pubmed/10343261", 
        "http://www.ncbi.nlm.nih.gov/pubmed/7477166", 
        "http://www.ncbi.nlm.nih.gov/pubmed/23958074", 
        "http://www.ncbi.nlm.nih.gov/pubmed/8389710", 
        "http://www.ncbi.nlm.nih.gov/pubmed/8594265"
    ], 
    "ideal_answer": [
        "Perioperative administration of synthetic thyroid hormone therapy have positive hemodynamic effects (consisting of increases cardiac output, lowered systemic vascular resistance) determining improved postoperative ventricular function, reduced the need for treatment with inotropic agents and mechanical devices, in the absence of relevant effects on outcome ad exception of lower incidence of atrial fibrillation."
    ], 
    "exact_answer": "no", 
    "concepts": [
        "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D047549", 
        "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D013963", 
        "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D020249", 
        "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D001026", 
        "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D003324", 
        "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D016896", 
        "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D014284", 
        "http://www.biosemantics.org/jochem#4275387", 
        "http://www.disease-ontology.org/api/metadata/DOID:3393"
    ], 
    "type": "yesno", 
    "id": "532673c4d6d3ac6a34000009", 
    "snippets": [
        {
            "offsetInBeginSection": 889, 
            "offsetInEndSection": 1204, 
            "text": "Serum T3 concentrations were significantly higher with fewer patients having T3 concentrations below the normal range in the T3 group than the placebo group throughout the postoperative period. Hemodynamic variables, postoperative inotrope requirement, and outcome variables showed no differences between the groups", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/23958074", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 496, 
            "offsetInEndSection": 835, 
            "text": "We conclude that although widespread interest has been shown on the use of thyroid hormones in the perioperative period, and the effect of cardiopulmonary bypass on thyroid hormone metabolism widely studied, there is no substantial evidence to justify routine use of thyroid hormones in patients undergoing coronary artery bypass grafting.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/18290900", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 1440, 
            "offsetInEndSection": 1588, 
            "text": "Treatment with GIK, T3, and GIK/T3 improves hemodynamic performance and results in reduced cTnI release in patients undergoing on-pump CABG surgery.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/16820580", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 1053, 
            "offsetInEndSection": 1222, 
            "text": "Perioperative administration of triiodothyronine increased cardiac output slightly and decreased systemic vascular resistance, but it had no effect on operative outcome.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/12213743", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 1614, 
            "offsetInEndSection": 2031, 
            "text": "Parenteral triiodothyronine given after crossclamp removal during elective coronary artery bypass grafting significantly improved postoperative ventricular function, reduced the need for treatment with inotropic agents and mechanical devices, and decreased the incidence of myocardial ischemia. The incidence of atrial fibrillation was slightly decreased, and the need for postoperative pacemaker support was reduced.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/10343261", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 1370, 
            "offsetInEndSection": 1486, 
            "text": "Perioperative T3 administration decreased the incidence and need for treatment of postoperative atrial fibrillation.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/8633935", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 1501, 
            "offsetInEndSection": 1625, 
            "text": " Intravenous T(3) does not have dramatic effects on hemodynamic variables in this setting as has been previously suggested. ", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/8594265", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 1978, 
            "offsetInEndSection": 2225, 
            "text": "Raising serum triiodothyronine concentrations in patients undergoing coronary-artery bypass surgery increases cardiac output and lowers systemic vascular resistance, but does not change outcome or alter the need for standard postoperative therapy.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/7477166", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 1166, 
            "offsetInEndSection": 1344, 
            "text": "No significant differences were noted in the pre and post CPB hemodynamics between the two groups for the most part of the study except that heart rate was increased in T3 group.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/7995828", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 1125, 
            "offsetInEndSection": 1366, 
            "text": "The haemodynamic parameters were no different between the two groups at any postoperative time point. Likewise, density and affinity of lymphocyte beta-adrenoceptors were not significantly different from pre-operative values in either group.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/8389710", 
            "endSection": "abstract"
        }
    ]
}